73 related articles for article (PubMed ID: 1930215)
1. Investigating the stereochemistry of binding to HIV-1 protease with inhibitors containing isomers of 4-amino-3-hydroxy-5-phenylpentanoic acid.
Raju B; Deshpande MS
Biochem Biophys Res Commun; 1991 Oct; 180(1):187-90. PubMed ID: 1930215
[TBL] [Abstract][Full Text] [Related]
2. Substrate analog inhibitors of HIV-1 protease containing phenylnorstatine as a transition state element.
Raju B; Deshpande MS
Biochem Biophys Res Commun; 1991 Oct; 180(1):181-6. PubMed ID: 1930214
[TBL] [Abstract][Full Text] [Related]
3. Studies of HIV-1 protease inhibitors. I. Incorporation of a reduced peptide, simple aminoalcohol, and statine analog at the scissile site of substrate sequences.
Sakurai M; Sugano M; Handa H; Komai T; Yagi R; Nishigaki T; Yabe Y
Chem Pharm Bull (Tokyo); 1993 Aug; 41(8):1369-77. PubMed ID: 8403085
[TBL] [Abstract][Full Text] [Related]
4. Peptide substrates and inhibitors of the HIV-1 protease.
Moore ML; Bryan WM; Fakhoury SA; Magaard VW; Huffman WF; Dayton BD; Meek TD; Hyland L; Dreyer GB; Metcalf BW
Biochem Biophys Res Commun; 1989 Mar; 159(2):420-5. PubMed ID: 2649094
[TBL] [Abstract][Full Text] [Related]
5. Small dipeptide-based HIV protease inhibitors containing the hydroxymethylcarbonyl isostere as an ideal transition-state mimic.
Kiso Y; Matsumoto H; Mizumoto S; Kimura T; Fujiwara Y; Akaji K
Biopolymers; 1999; 51(1):59-68. PubMed ID: 10380353
[TBL] [Abstract][Full Text] [Related]
6. Synthesis of analogues of the carboxyl protease inhibitor pepstatin. Effects of structure on inhibition of pepsin and renin.
Rich DH; Sun ET; Ulm E
J Med Chem; 1980 Jan; 23(1):27-33. PubMed ID: 6767029
[TBL] [Abstract][Full Text] [Related]
7. Inhibitors of HIV-1 proteinase containing 2-heterosubstituted 4-amino-3-hydroxy-5-phenylpentanoic acid: synthesis, enzyme inhibition, and antiviral activity.
Scholz D; Billich A; Charpiot B; Ettmayer P; Lehr P; Rosenwirth B; Schreiner E; Gstach H
J Med Chem; 1994 Sep; 37(19):3079-89. PubMed ID: 7932531
[TBL] [Abstract][Full Text] [Related]
8. Two-step binding mechanism for HIV protease inhibitors.
Furfine ES; D'Souza E; Ingold KJ; Leban JJ; Spector T; Porter DJ
Biochemistry; 1992 Sep; 31(34):7886-91. PubMed ID: 1510976
[TBL] [Abstract][Full Text] [Related]
9. Total chemical synthesis of a D-enzyme: the enantiomers of HIV-1 protease show reciprocal chiral substrate specificity [corrected].
Milton RC; Milton SC; Kent SB
Science; 1992 Jun; 256(5062):1445-8. PubMed ID: 1604320
[TBL] [Abstract][Full Text] [Related]
10. Specificity mapping of HIV-1 protease by reduced bond inhibitors.
Majer P; Urban J; Gregorová E; Konvalinka J; Novek P; Stehlíková J; Andreánsky M; Sedlácek J; Strop P
Arch Biochem Biophys; 1993 Jul; 304(1):1-8. PubMed ID: 8323274
[TBL] [Abstract][Full Text] [Related]
11. Potent HIV protease inhibitors containing a novel (hydroxyethyl)amide isostere.
Beaulieu PL; Wernic D; Abraham A; Anderson PC; Bogri T; Bousquet Y; Croteau G; Guse I; Lamarre D; Liard F; Paris W; Thibeault D; Pav S; Tong L
J Med Chem; 1997 Jul; 40(14):2164-76. PubMed ID: 9216835
[TBL] [Abstract][Full Text] [Related]
12. Inhibitors of human immunodeficiency virus type 1 protease containing 2-aminobenzyl-substituted 4-amino-3-hydroxy-5-phenylpentanoic acid: synthesis, activity, and oral bioavailability.
Lehr P; Billich A; Charpiot B; Ettmayer P; Scholz D; Rosenwirth B; Gstach H
J Med Chem; 1996 May; 39(10):2060-7. PubMed ID: 8642565
[TBL] [Abstract][Full Text] [Related]
13. Nonpeptidal P2 ligands for HIV protease inhibitors: structure-based design, synthesis, and biological evaluation.
Ghosh AK; Kincaid JF; Walters DE; Chen Y; Chaudhuri NC; Thompson WJ; Culberson C; Fitzgerald PM; Lee HY; McKee SP; Munson PM; Duong TT; Darke PL; Zugay JA; Schleif WA; Axel MG; Lin J; Huff JR
J Med Chem; 1996 Aug; 39(17):3278-90. PubMed ID: 8765511
[TBL] [Abstract][Full Text] [Related]
14. Alteration of substrate and inhibitor specificity of feline immunodeficiency virus protease.
Lin YC; Beck Z; Lee T; Le VD; Morris GM; Olson AJ; Wong CH; Elder JH
J Virol; 2000 May; 74(10):4710-20. PubMed ID: 10775609
[TBL] [Abstract][Full Text] [Related]
15. Combination of non-natural D-amino acid derivatives and allophenylnorstatine-dimethylthioproline scaffold in HIV protease inhibitors have high efficacy in mutant HIV.
Nakatani S; Hidaka K; Ami E; Nakahara K; Sato A; Nguyen JT; Hamada Y; Hori Y; Ohnishi N; Nagai A; Kimura T; Hayashi Y; Kiso Y
J Med Chem; 2008 May; 51(10):2992-3004. PubMed ID: 18426195
[TBL] [Abstract][Full Text] [Related]
16. Fullerene-based inhibitors of HIV-1 protease.
Strom TA; Durdagi S; Ersoz SS; Salmas RE; Supuran CT; Barron AR
J Pept Sci; 2015 Dec; 21(12):862-70. PubMed ID: 26767741
[TBL] [Abstract][Full Text] [Related]
17. Crystal structure of a complex of HIV-1 protease with a dihydroxyethylene-containing inhibitor: comparisons with molecular modeling.
Thanki N; Rao JK; Foundling SI; Howe WJ; Moon JB; Hui JO; Tomasselli AG; Heinrikson RL; Thaisrivongs S; Wlodawer A
Protein Sci; 1992 Aug; 1(8):1061-72. PubMed ID: 1304383
[TBL] [Abstract][Full Text] [Related]
18. Analysis of the S3 and S3' subsite specificities of feline immunodeficiency virus (FIV) protease: development of a broad-based protease inhibitor efficacious against FIV, SIV, and HIV in vitro and ex vivo.
Lee T; Laco GS; Torbett BE; Fox HS; Lerner DL; Elder JH; Wong CH
Proc Natl Acad Sci U S A; 1998 Feb; 95(3):939-44. PubMed ID: 9448264
[TBL] [Abstract][Full Text] [Related]
19. Role of hydroxyl group and R/S configuration of isostere in binding properties of HIV-1 protease inhibitors.
Petroková H; Dusková J; Dohnálek J; Skálová T; Vondrácková-Buchtelová E; Soucek M; Konvalinka J; Brynda J; Fábry M; Sedlácek J; Hasek J
Eur J Biochem; 2004 Nov; 271(22):4451-61. PubMed ID: 15560786
[TBL] [Abstract][Full Text] [Related]
20. Structural role of the 30's loop in determining the ligand specificity of the human immunodeficiency virus protease.
Swairjo MA; Towler EM; Debouck C; Abdel-Meguid SS
Biochemistry; 1998 Aug; 37(31):10928-36. PubMed ID: 9692985
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
